The study, run by the Danish-led Bandim Health Project, aimed to measure five-year outcomes by giving the hepatitis B vaccine to some infants at birth while delaying it for others until six weeks. Guinea-Bissau's judicial police raided the organization's facilities in Bissau in mid-October, seizing vaccine supplies to determine if safety protocols had been violated. A researcher associated with the initiative subsequently confirmed its termination following the failure to secure mandatory government authorization. While supply constraints currently delay routine immunization for up to six weeks, the country is actively striving to achieve universal birth-dose coverage by 2028.
Key points
The World Health Organization condemned the 14,000-infant clinical trial as unethical for…: The World Health Organization condemned the 14,000-infant clinical trial as unethical for deliberately depriving newborn babies of recommended preventive care.
Danish researchers leading the Bandim Health Project have previously faced professional a…: Danish researchers leading the Bandim Health Project have previously faced professional allegations of suppressing data that conflicted with their vaccine theories.
Guinea-Bissau officials are moving to implement universal at-birth hepatitis B immunizati…: Guinea-Bissau officials are moving to implement universal at-birth hepatitis B immunization across the country by 2028.
Sources checked by our analysis pipeline: 1
Experts have said the US-funded trial would deny critical vaccines to thousands of infants.
Guinea-Bissau has reportedly halted a controversial United States-funded hepatitis B virus vaccine (HBV) trial which drew global scrutiny when experts said it involved withholding lifesaving shots from thousands of babies.
The trial failed to gain the necessary government approval, one researcher involved in the project said in a statement, adding that the end of the trial was a “significant setback” for African science.
Recommended Stories
list of 4 items- list 1 of 4Port Sudan families can barely afford water as shortages persist
- list 2 of 4Israel restricting treatment for 1,100 child amputees in Gaza: NGO
- list 3 of 4Dakar Youth Olympics: Who gets to hold the flame?
- list 4 of 4Education under fire: Gaza’s children face death on their way to school
Officials have not commented.
The West African nation’s judicial police said in mid-October that it had raided the facilities of the research group leading the project in the capital, Bissau, and seized vaccine batches.
Authorities said inquiries were continuing to determine…
Healthcare facilities nationwide are confronting severe financial and operational pressures as shifting policy environments threaten patient access to care. Reductions in Medicaid funding alongside widespread drops in insurance enrollment will place major strain on provider budgets. Institutions must navigate these mounting resource deficits while attempting to sustain their standard service levels.
Chinese regulatory authorities are imposing fresh restrictions on investigator-initiated trials following recent patient fatalities during clinical testing. This policy change curtails an avenue that international drug developers long relied on for rapid and affordable early-phase human studies. As a consequence, American biotechnology firms are losing a dependable shortcut to accelerate their clinical development pipelines.
An individual perspective outlines the sensory and physical realities associated with wearing hearing technology in both ears. The account details personal observations regarding the psychophysics experienced by a bilateral cochlear device recipient. Such insights offer meaningful context into how auditory stimuli are processed by implant recipients in daily life.